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INTRODUCTION: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of
the gastrointestinal tract and they derived from transformed neoplastic precursors of Cajal’s interstitial
cell (ICC).
PRESENTATION OF THE CASE: We are presenting a sporadic and exemplary case of 42 multiple GISTs
in a young female patient. Our patient showed anemia for the gastric GIST bleeding and only after
other tumors were instrumentally and intra-surgery discovered. The patient showed genetic mutation
V559A/1676 T>C of the juxtamembrane domain of the exon 11 causing the replacement of Valine with
Alanine in the 559 codon.
DISCUSSION:GISTS estimated annual incidence is 12–14permillion.MultipleGISTs associatedwith famil-
iarity or hereditary syndromes are described only in few case reports and sporadic mGISTs have not been
studied yet. Literature review has been done.
CONCLUSION: We are presenting a sporadic and exemplary case of 42 multiple GISTs in a young female
patient localized trough out all the gastrointestinal tract. This is the only case of sporadic multiple GISTs
reported in literature.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Gastrointestinal stromal tumors (GISTs) are the most common
mesenchymal tumors of the gastrointestinal tract and they derived
from transformed neoplastic precursors of Cajal’s interstitial cell
(ICC).
Their estimated annual incidence is 12–14 per million [1].
Stomach and small intestine are the most commonly affected
organs. Rare cases of primary GISTs originating outside the gas-
trointestinal tract have also been reported, although the actual
existence of extra gastrointestinal GISTs is still debated.
GISTs can exhibit a wide spectrum of clinical behaviors that
could go from indolent and curable disorders to highly malignant
diseases that could metastasize and become lethal.
KIT and PDGFR- activation seems to be a central tumorigenic
event in the development of GISTs. KIT mutations are identiﬁed
in 60–90% of cases [2]. KIT mutations in sporadic GISTs have been
found in 4 different regions: extracellular domain (exon 9), jux-
tamembrane domain (exon 11), tyrosine kinase I domain (exon 13),
and tyrosine kinase II domain (exon 17) [3].
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Most GISTs occur sporadically in patients between 50 and 60
years.
GISTs are generally considered solitary tumors and the occur-
rence as multiple primary tumors is an exceptional event, usually
restricted to familial GISTs or distinct pediatrics syndromes such as
neuroﬁbromatosis type 1 (NF1) or Carney’s syndrome.
Multiple GISTs (MPGs) can be divided into 4 subtypes: (1) famil-
ial multiple GISTs with germline mutations of KIT or PDGFR-
genes, (2) multiple GISTs associated with NF-1 without mutations
of KIT or PDGFR-, (3)multipleGISTs associatedwith Carney’s triad
without mutations of KIT and PDGFR- and ﬁnally (4) sporadic
multiple GISTs [4].
Multiple GISTs associated with familiarity or hereditary syn-
dromes are described only in few case reports and sporadic mGISTs
have not been studied yet.
We are presenting a sporadic and exemplary case of 42 multiple
GISTs in a young female patient.
In addition a literature review was made.
2. Case presentation
A 51-year-old female with a negative familial history for can-
cer was admitted to our General and Emergency Department for
melena and anemia (hemoglobin value: 5.5 g/dl) without any signs
http://dx.doi.org/10.1016/j.ijscr.2015.01.025
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Fig. 1. (a) Gastric GIST; (b and c) duodenal GIST.
of hemodynamic instability. Transfusions of red packed cells were
started immediately. A ﬁrst attempt to perform an upper gastroin-
testinal endoscopy was poorly diagnostic due to the presence of
undigestedmaterial. The exam revealed a yellowish tumor covered
with smooth mucosa just below the cardia. A second endoscopy
revealed 3 polypoid tumors: a 3 cm lesion just below the cardia
with recent signs of bleeding, a 0.8 cm lesion in the gastric body
and 1,5 cm lesion in the antrum. Multiple biopsies were taken dur-
ing this procedure. In order to investigate the lesions’ origin an
endoscopy ultrasonography was done and it showed that all of
them seem to originate from the submucosal layers. Biopsies of
these gastric lesions were inconclusive. Tumor markers CEA, CA
19-9, CA 15-3, CA 125 and FP were within normal ranges.
A staging CT revealed a greater diameter of the lesion below the
cardia (71×48mm); it also showed twoother tumors located in the
second duodenal portion (31mm in diameter) and in the ﬁrst jeju-
nal loop (30mm in diameter), respectively (Fig. 1). No metastatic
localizations nor in liver or lungs were detectable and neither per-
itoneal dissemination nor lymphnodal spreading were revealed.
An abdominal MRI highlighted multiple polypoid masses aris-
ing in the small bowel and in the cecum, those lesions appeared
hyper-intense and in homogeneous due to necrosis and recent
bleeding. The radiological ﬁndings were compatible with multiple
mesenchymal tumors without metastatic spreading.
A surgery procedure was scheduled. Antibiotic (Cefazolin
2g+Metronidazole 500mg i.v.) and antithrombotic (Clexane 4000
I.U. s.c.) prophylaxis was administered thirty minutes before
surgery. A median laparotomy with complete abdominal explo-
ration was performed to rule out metastatic spreading. In
consideration of the location and size of the gastric tumor a total
gastrectomy with perigastric lymphnodal clearance was indicated.
An end to side, circular, Roux-en-Y esophago-jejunostomywas cre-
ated.
Local surgical resection was performed for duodenal GISTs.
Enucleationof the jejunal and ileal lesionswasperformed.Distal
ileum and proximal colon were resected and intestinal tract was
restored by means of side-to-side anastomosis between the ileum
and the ascending colon. Two drains were positioned close to the
esophagojejunostomy, while another drain was positioned in the
Douglas pouch. A nasojejunal tube was left in place.
The postoperative course was uneventful. Full bowel move-
ment with stool passage was recovered in the third post-operative
day. The patient underwent a water-soluble swallow test on the
ﬁfth post-operative day, which did not show anastomotic leak or
obstruction. Oral intake was resumed in the same day and drains
were removed. Medication of the median incision took place every
48–72h according with dressing status. Patient was discharge in
good general conditions on the ninth post-operative day.
Pathologic report revealed 42 neoplasms arising from the sub-
mucosal, intramuscular or subserosal layer of the gastrointestinal
tractwith surface ulceration. At gross examination the lesionswere
well circumscribed although a true capsule was not present. At
cut the surface was gray to pink in color with concomitant areas
of cystic degeneration, infarction, hemorrhage and necrosis. Main
microscopic features recorded were spindle or epithelioid cells
patterns. Immunohistochemistry revealed a strong positivity for
CD-117 and DOG-1, conﬁrming the diagnosis of multiple sporadic
GISTs.
The median lesion size was 19.15mm with a standard deviation
of 15.67 (range 6–65). The patient underwent adjuvant chemother-
apy with glivec and both CT and pet-CT after 12 months from the
surgery were negative for disease progression.
3. Discussion
MPGsgenerally occurred in a sporadic or familial settingor asso-
ciated with hereditary syndromes.
Most GISTs occur sporadically and multiplicity is very rare.
Frequently, MPGs could be observed in pediatric patients
or in patients affected by hereditary GISTs, NF1, or paragan-
glioma/sarcoma and Carney’s triad syndromes [5–7]. Contrary to
the familial GISTs, no mutations of KIT or PDGFR- have been
reported in the majority of the syndromic, pediatric and NF1-
related GIST variants.
All these are well-deﬁned entities that can be easily distin-
guished from common sporadic GISTs based on their peculiar
clinicopathological features.
As a matter of fact, patients, according to the mutation type,
could show some clinical characteristics such as urticaria pigmen-
tosa, mastocytosis, and/or skin hyper pigmentation.
Moreover, GISTs in these cases generally develop at early age.
Presence of multicentric GISTs has also been observed and
described in familial settings. These patients usually develop
tumors in the small intestine, which may be associated with hyper-
plasia of ICC.
Patients with germline mutations of KIT, similarly to sporadic
gist patients, may have genetic variations of the juxtamembrane
domain (exon 11), although mutations involving the extracellular
domain (exon 9), kinase I domain (exon 13), and kinase II domain
(exon17) of KIT gene.
C-KIT gene is a tyrosine kinase receptor normally expressed by
the interstitial Cajal cells known as the origin of GISTs.
The sporadic multiple GISTs are generally low in number, local-
ized in the stomach or small intestine with a benign histology and
positive for CD-117.
Multiplicity in sporadic GIST patients without family history or
NF-1 is uncommon and it was described only in few reports.
At the beginning, gastrointestinal mGISTs were considered as
advanced, metastatic disease because they were viewed as the
dissemination from the single biggest GIST. This paradigm was
changed by the presence of two reports in which authors described
multifocal GISTs in the same patient with well deﬁned clinical and
pathological characteristics.
Kang’s [8] work described the coexistence of multifocal GIST
with different KIT mutations showing the different origin of each
neoplasia.
Haller [9] reported 4 cases of multifocal sporadic GISTs.
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Fig. 2. Sequencing of exon 11 shows a heterozygous mutation in tumor tissue DNA:
a T–Y (T or C) base-pair change (black arrow), resulting in a substitution of Valine
for Alanine at position 559 (V559A).
Different mutations of KIT and PDGFR- were present among
individual tumors of each patient, and germline mutation of KIT
and PDGFR- could be excluded.
Thus, the presence of different Kit and PDGRF- mutations in
multiple GISTs of the same patient, the lack of mutation in normal
tissue and the absence of ICC hyperplasia addressed to coincidental
multicentric occurrence of sporadic GISTs.
Often in sporadic mGISTs adults there was a bigger neoplasia
that caused the clinical symptomatic patient state.
Gasparottoet al. [10] inherworkexplained theoriginof sporadic
MPGs. She suggested that in these patients widespread priming of
GIST precursor mesenchymal cells could be implicated in sporadic
mGISTs origin.
The existence of tumor multiplicity in the context of adult GIST
suggests that, in the presence of multifocal presentation, an accu-
rate molecular characterization of the different tumor localizations
should be taken into account for proper patient staging and plan-
ning of therapy.
KIT/PDGFR- mutation status is an important predictor of
responsiveness to imatinib.
Accurate molecular characterization should be done because
sporadic MPGs may display different mutations with varying
imatinib sensitivity, planning the adeguate therapy although the
benign behaviour of GIST.
Our patient showed anemia for the gastric GIST bleeding and
only after other tumors were instrumentally and intraoperative
discovered. The patient showed the genetic mutation V559A/1676
T>C of the juxtamembrane domain of the exon 11 causing the
replacementofValinewithAlanine in the559codonas Fig. 2 shows.
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